Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $0.0 | $0.0 | ($0.0) | ($0.0) | ($0.0) | ($0.0) | ($0.0) | ($9.5) | ($9.4) | ($14.8) | ($4.6) | ($8.6) | ($20.5) | ($12.3) | ($2.5) | ($2.4) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month EPS is ($2.3), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s EPS growth was (0.9%). The average annual EPS growth rates for Aadi Bioscience, Inc. have been (16.0%) over the past three years, (23.4%) over the past five years.
Over the last year, Aadi Bioscience, Inc.'s EPS growth was (0.9%), which is lower than industry growth of (0.1%). It indicates that Aadi Bioscience, Inc.'s EPS growth is Bad.